26807-65-8
- Product Name:Indapamide
- Molecular Formula:C16H16ClN3O3S
- Purity:99%
- Molecular Weight:365.84
Product Details:
CasNo: 26807-65-8
Molecular Formula: C16H16ClN3O3S
Appearance: Crystalline solid
Wholesale! Buy High Grade Indapamide 26807-65-8 Safe Delivery
- Molecular Formula:C16H16ClN3O3S
- Molecular Weight:365.84
- Appearance/Colour:Crystalline solid
- Melting Point:160-162 °C
- Refractive Index:1.693
- Boiling Point:110.4°C (rough estimate)
- PKA:pKa (25°) 8.8 ± 0.2
- PSA:100.88000
- Density:1.51 g/cm3
- LogP:4.32040
Indapamide(Cas 26807-65-8) Usage
Description |
Indapamide is a type of medicine classified as a diuretic, commonly known as a "water pill." It works by increasing urine production, helping to eliminate excess fluid from the body. Indapamide is primarily used to treat high blood pressure (hypertension) and salt and fluid retention (edema) associated with congestive heart failure. |
Uses |
High Blood Pressure (Hypertension): Indapamide is prescribed alone or in combination with other medications to manage high blood pressure. By reducing blood volume, it helps decrease the workload on the heart and arteries, thus lowering blood pressure. It is used to treat salt and fluid retention caused by congestive heart failure. By promoting diuresis, indapamide helps reduce fluid buildup in the body, relieving symptoms such as swelling and shortness of breath. |
Category toxic |
Substances |
Toxicity grading |
Medium toxicity |
Acute toxicity |
Oral-rat LD50:> 3000 mg/kg; Oral-mouse LD50:> 3000 mg/kg. |
Brand name |
Lozol (Sanofi Aventis). |
InChI:InChI=1/C16H16ClN3O3S/c1-10-8-11-4-2-3-5-14(11)20(10)19-16(21)12-6-7-13(17)15(9-12)24(18,22)23/h2-7,9-10H,8H2,1H3,(H,19,21)(H2,18,22,23)
26807-65-8 Relevant articles
One-pot Synthesis of the Indole Derivative 4-Chloro-3-sulphamoyl-N-(2,3-dihydro-2-methyl-1H-indol-1-yl)benzamide (Indapamide)
Ziobro, Barbara,Sienkiewicz, Barbara,Kowalski, Piotr
, p. 95 - 97 (2004)
New methods for the synthesis the indole...
Pharmacokinetics and clinical pharmacology of indapamide
Frank S Caruso Ph.D., Romana R Szabadi Ph.D., Robert A Vukovich Ph.D.
American Heart Journal Volume 106, Issue 1, Part 2, July 1983, Pages 212-220
Disappearance of indapamide from the blood is biphasic, with a terminal half-life of approximately 16 hours. Renal clearance represents less than 10% of the total systemic clearance of the parent drug, showing the dominant role of hepatic clearance. Studies of 14C-labeled indapamide in humans demonstrate that 70% of the radioactivity is excreted in urine and 23% in feces.
26807-65-8 Process route
- 63968-75-2
Dehydroindapamide
- 26807-65-8,77083-52-4
Indapamide
Conditions | Yield |
---|---|
With sodium tetrahydroborate; hexachloroplatinic acid; hydrogen; In ethanol; at 10 ℃; for 1h;
|
99.3% |
-
N-amino-2-methylindoline hydrochloride
-
C8H5Cl2NO5S
- 26807-65-8,77083-52-4
Indapamide
Conditions | Yield |
---|---|
With triethylamine; In dichloromethane; at 15 ℃; for 6h; Temperature; Solvent;
|
96.89% |
26807-65-8 Upstream products
-
1205-30-7
4-chloro-3-sulphamoylbenzoic acid
-
31529-46-1
1-amino-2,3-dihydro-2-methylindole
-
70049-77-3
3-(aminosulfonyl)-4-chlorobenzoyl chloride
-
7440-44-0
pyrographite
26807-65-8 Downstream products
-
63968-75-2
Dehydroindapamide
-
77083-52-4
(R)-indapamide
-
77083-52-4
(S)-indapamide
-
1108610-87-2
C8Cl2N2O2*C16H16ClN3O3S
Relevant Products
-
Tirofiban Hcl
CAS:142373-60-2
-
Ethyl 1-methylpiperidine-3-carboxylate
CAS:5166-67-6
-
Lasmiditan Hemisuccinate
CAS:439239-92-6